Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
about
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesInduction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivoEpstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.Regulation of autophagic activation by Rta of Epstein-Barr virus via the extracellular signal-regulated kinase pathway.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infectionVirus and cell RNAs expressed during Epstein-Barr virus replicationAn integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndromeProtein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismEpstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.Understanding Epstein-Barr Virus Life Cycle with Proteomics: A Temporal Analysis of Ubiquitination During Virus Reactivation.Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cellsRegulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus.Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C.A rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray.CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.Regulation of gammaherpesvirus lytic replication by endoplasmic reticulum stress-induced transcription factors ATF4 and CHOP.
P2860
Q24681203-B25A3F47-C142-4260-AF60-8BEC09111508Q33755168-F3D252E5-80F2-4C21-BD4B-9551B335A55BQ33843334-38C433AD-3F8D-40A0-AB53-9DB666D65713Q34261601-039F74DE-A8D4-4F4D-AF26-F6199C6F952BQ34302121-B9517198-063A-4CAE-BB93-0CF6018E1B05Q34381037-FD918506-535A-4AA0-96BB-091A76EE7F17Q34434702-9AB3DEE0-22B9-4423-9FB3-00FE20A22AF6Q35000168-0D8B3EE4-0905-453F-9D64-346F0A47C29DQ35823798-A51A7E07-8087-4976-9107-D7D35943185CQ35832930-11D1F62B-760A-4ED2-832A-74FD377628C6Q36442795-D5B64967-D97A-47A3-817F-755B51216F40Q36630074-BEFC3299-16F7-4239-B5A0-A53EDF8850A9Q36646940-C0E6A779-D676-434A-8C76-76ECE646598DQ38921560-8D7EFCB3-362C-4009-8909-9659BBB66E13Q39351834-C7F28DF5-9152-48B8-BDCA-540AFE4F4191Q39593135-178055D3-375B-4325-9BF4-2ED9DD9C90F2Q39594354-A4524D67-69D5-4DF5-AA8B-1C458C3657E4Q39596248-F3A17456-6450-4BE5-AF2E-A9F52F17356BQ39960975-B2F4A169-B957-4AC7-B94B-C2F2B1BDDCA8Q40045269-CC1DB5C7-5FC5-40F2-938F-3FCB0C248D3BQ40048949-4075D40A-CAAE-4D85-BD6D-87398AF46505Q40115777-C698601C-E241-47B3-8479-AF344E31B530Q40125731-63E3A416-710F-4627-B001-F46422E774F4Q40271086-E5B5CDCA-B233-4102-877D-FFF99860B26DQ40563964-51610F2F-EE67-4BF4-8D2F-F50CCDB427E6Q40794281-3E41C717-DEAD-48AB-9AD3-3656E162D195Q41983297-C1C86DE7-0349-497E-88D2-F74B1A8F5120Q47228609-D117E622-5E16-43A0-89DF-D7B12F711247
P2860
Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Activation of latent EBV via a ...... tt's lymphoma cell line Akata.
@en
type
label
Activation of latent EBV via a ...... tt's lymphoma cell line Akata.
@en
prefLabel
Activation of latent EBV via a ...... tt's lymphoma cell line Akata.
@en
P2093
P1476
Activation of latent EBV via a ...... itt's lymphoma cell line Akata
@en
P2093
Humphreys RE
Sairenji T
P304
P407
P577
1990-06-01T00:00:00Z